Prosecution Insights
Last updated: August 17, 2026

Examiner: KALLAL, ROBERT JAMES

Tech Center 2100 • Art Units: 1671 1685 1699 2146

This examiner grants 61% of resolved cases

Performance Statistics

60.6%
Allow Rate
+5.6% vs TC avg
133
Total Applications
+33.7%
Interview Lift
1541
Avg Prosecution Days
Based on 99 resolved cases, 2023–2026

Rejection Statute Breakdown

35.6%
§101 Eligibility
7.6%
§102 Novelty
29.8%
§103 Obviousness
22.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
16850838 FEATURE QUANTITY CALCULATING METHOD, FEATURE QUANTITY CALCULATING PROGRAM, AND FEATURE QUANTITY CALCULATING DEVICE, SCREENING METHOD, SCREENING PROGRAM, AND SCREENING DEVICE, COMPOUND CREATING METHOD, COMPOUND CREATING PROGRAM, AND COMPOUND CREATING DEVICE Non-Final OA FUJIFILM Corporation
17440993 COMPUTERIZED SYSTEM AND METHOD FOR ANTIGEN-INDEPENDENT DE NOVO PREDICTION OF CANCER-ASSOCIATED TCR REPERTOIRE Final Rejection Board of Regents of the University of Texas System
16952153 IDENTIFYING GENETIC SEQUENCE EXPRESSION PROFILES ACCORDING TO CLASSIFICATION FEATURE SETS Non-Final OA International Business Machines Corporation
17805138 SIGNAL-TO-NOISE-RATIO METRIC FOR DETERMINING NUCLEOTIDE-BASE CALLS AND BASE-CALL QUALITY Final Rejection Illumina, Inc.
18170396 EPITOPE MIMICS Non-Final OA IOGENETICS, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month